138 related articles for article (PubMed ID: 20713906)
21. Cyclooxygenase inhibition in patients with coronary artery disease.
Frishman WH
J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
[No Abstract] [Full Text] [Related]
22. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
23. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of unresponsiveness to aspirin and/or clopidogrel in patients with stable coronary heart disease.
Lordkipanidzé M; Diodati JG; Schampaert E; Palisaitis DA; Pharand C
Am J Cardiol; 2009 Nov; 104(9):1189-93. PubMed ID: 19840560
[TBL] [Abstract][Full Text] [Related]
25. Platelet aspirin resistance in ED patients with suspected acute coronary syndrome.
Glauser J; Emerman CL; Bhatt DL; Peacock WF
Am J Emerg Med; 2010 May; 28(4):440-4. PubMed ID: 20466222
[TBL] [Abstract][Full Text] [Related]
26. Comment on: DiChiara et al. (2007) The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study: Diabetes 56:3014-3019, 2007.
Klein PS
Diabetes; 2008 May; 57(5):e10; author reply e11. PubMed ID: 18443367
[No Abstract] [Full Text] [Related]
27. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
[TBL] [Abstract][Full Text] [Related]
28. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease.
Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y
Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624
[TBL] [Abstract][Full Text] [Related]
29. Heritability of platelet responsiveness to aspirin in activation pathways directly and indirectly related to cyclooxygenase-1.
Faraday N; Yanek LR; Mathias R; Herrera-Galeano JE; Vaidya D; Moy TF; Fallin MD; Wilson AF; Bray PF; Becker LC; Becker DM
Circulation; 2007 May; 115(19):2490-6. PubMed ID: 17470694
[TBL] [Abstract][Full Text] [Related]
30. Aspirin resistance: is this term meaningful?
Violi F; Pignatelli P
Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
[TBL] [Abstract][Full Text] [Related]
31. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
32. Measurement of the platelet retention rate in a column of collagen-coated beads is useful for the assessment of efficacy of antiplatelet therapy.
Mende A; Obata JE; Sano K; Hirano M; Kitta Y; Kodama Y; Nakamura T; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Satoh K; Ozaki Y; Yano T; Kugiyama K
Thromb Res; 2009 Apr; 123(6):856-61. PubMed ID: 19004478
[TBL] [Abstract][Full Text] [Related]
33. Aspirin and clopidogrel resistance-a myth or reality: an update.
Gupta S; Gupta MM
Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
[No Abstract] [Full Text] [Related]
34. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry.
Nielsen HL; Kristensen SD; Thygesen SS; Mortensen J; Pedersen SB; Grove EL; Hvas AM
Thromb Res; 2008; 123(2):267-73. PubMed ID: 18499236
[TBL] [Abstract][Full Text] [Related]
35. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
36. Screening for aspirin resistance in stable coronary artery patients by three different tests.
Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
[TBL] [Abstract][Full Text] [Related]
37. Monitoring platelet function to reduce the risk of ischemic and bleeding complications.
Price MJ
Am J Cardiol; 2009 Feb; 103(3 Suppl):35A-39A. PubMed ID: 19166711
[TBL] [Abstract][Full Text] [Related]
38. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
[TBL] [Abstract][Full Text] [Related]
39. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
[No Abstract] [Full Text] [Related]
40. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
